ALMKT:EPA
Mauna Kea Technologies SA
0,092 €
0,00%
(0,00) 1 p
13. nov, 17:35:01 GMT +1 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse ALMKT põhistatistika genereerimine…
Ava
0,09 €
Kõrge
0,10 €
Madal
0,09 €
Turu kapit.
18,14 mln
Keskm. maht
541,14 tuh
Maht
75,16 tuh
Hinna ja tulu suhe
0,79
52 näd kõrgeim
0,23 €
52 näd madalaim
0,07 €
Aktsiatulu
0,12 €
Käibivad aktsiad
195,26 mln
Töötajate arv
56
Ava
0,09 €
Kõrge
0,10 €
Madal
0,09 €
Turu kapit.
18,14 mln
Keskm. maht
541,14 tuh
Maht
75,16 tuh
Hinna ja tulu suhe
0,79
52 näd kõrgeim
0,23 €
52 näd madalaim
0,07 €
Aktsiatulu
0,12 €
Käibivad aktsiad
195,26 mln
Töötajate arv
56
Uudised
Veebiallikatest ja uudistepartneritelt
Yahoo! Finance Canada
·
15 minuti eest
AMN,HLF,BSBK,FXNC,IMRX,MRBK,FRST,TISI,GRNT,TPL,FTHM,VSTS,RVSB,GEF-B,BCRX,TMCI,SABR,SHEN,DCGO,NBBK,USCB | Stock Prices | Quote Comparison - Yahoo Finance
Bloomberg.com
·
18 tunni eest
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
AP News
·
1 päeva eest
Microsoft outage shows the risks of relying on a single technology provider for essential services
Investor's Business Daily
·
4 tunni eest
Futures Loom As Bitcoin Dives In Shaky Rally. What To Do Now.
Profiil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Teave üksuse Mauna Kea Technologies SA kohta
TegevjuhtSacha Loiseau
Töötajad56
Asutatud2000
Peakontorid-
SektorHealth Care
Valdkond-
Veebisaitmaunakeatech.com